The case for & against
Bull & Bear analysis
Bearish
22nd Century Group, Inc. (NASDAQ: XXII) is a pioneering biopharmaceutical company focused on tobacco harm reduction through its proprietary technology to produce low-nicotine tobacco strains, specifically marketed under the VLN (Very Low Nicotine) brand. The company is positioned uniquely in the tobacco market as the only producer of FDA-authorized low-nicotine cigarette alternatives, targeting a substantial addressable market of smokers seeking healthier options and aligning with global regulatory shifts towards reduced nicotine products.
Bull says
- ↑Q1 ’26 net revenue rose 16.1% QoQ to $4.1M, showing early VLN traction
- ↑Exclusive FDA authorization for VLN low-nicotine cigarettes amid tightening regulations
- ↑Targets $58B serviceable market with 70% of smokers seeking lower-nicotine options
- ↑$9.5M cash provides runway for marketing and expansion to 5,000 outlets
- ↑Positive growth and value factor signals support revaluation potential
- ↑Regulatory tailwinds and rising harm-reduction demand could boost adoption
Bear says
- ↓Operating loss of $3M in Q1 ’26 underscores ongoing unprofitability
- ↓Negative profitability factors and weak earnings yield flag cash-flow risks
- ↓Two-week share decline of 27% and high volatility deter risk-averse buyers
- ↓Financhill score of 4/100 and forecasts to $3.95–$0.39 by 2030 point lower
- ↓Scaling VLN adoption faces addiction hurdles and stiff competition
- ↓Low institutional interest and negative cash-flow outlook constrain growth
Investment themes with XXII
Tobacco↑ +0.22%
Producers and distributors of tobacco products
BTI · TPB · JAPAY
Most Shorted Stocks↑ +0.54%
Stocks with highest short interest
LITE · FSLY · SPHR
Earnings Call · Q1 2025 · Mgmt. Guidance
Updated 06-04-2026bullish
Transcript signals
Bull points
- As the foundational pieces of our strategy continue to be laid and we execute growth initiatives, we are set up for success in improving financial results for the remainder of 2025.
- Starting from the top, net revenue was $6 million in the first quarter 2025, increased 50% sequentially from $4 million in the fourth quarter 2024.
- Total cartons sold were 476,000, increased 41% versus 338,000 in the fourth quarter.
Bear points
- The gross margin was a loss of $0.6 million, also an improvement of 50% from the prior quarter.
- First quarter 2025 net loss from continuing operations improved to 3.3 million from 4.2 million in the preceding quarter. EPS improved to a loss of $1.89 a share compared to 10.59 a share.
Read full transcript analysis ›